Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgery

This publication has 9 references indexed in Scilit:

• Inhibition of the early stages of the thrombin generation reaction by various glycosaminoglycans
  Thrombosis Research, 1990
• The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma
  Thrombosis Research, 1990
• Clinical Studies with Low Molecular Weight Heparins in the Prevention and Treatment of Venous Thromboembolism
  Annals of the New York Academy of Sciences, 1989
• The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg
  The Journal of Clinical Pharmacology, 1988
• Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis
  British Journal of Surgery, 1988
• The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin
  Biochemical Journal, 1987
• Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip Replacement
  New England Journal of Medicine, 1983
• VENOUS THROMBOEMBOLISM ASSOCIATED WITH GYNECOLOGIC SURGERY
  Clinical Obstetrics and Gynecology, 1980
• LOW DOSES OF SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP VEIN THROMBOSIS AFTER GYNAECOLOGICAL SURGERY
  BJOG: An International Journal of Obstetrics and Gynaecology, 1973